Association of adipocyte genes with ASP expression: A microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  MacLaren, Robin E ^a,b   Cui, Wei ^a,b   Lu, Huiling ^a   Simard, Serge ^a   Cianflone, Katherine ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPOPHILIN; ADIPSIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CD36 ANTIGEN; COMPLEMENT COMPONENT C3; DIACYLGLYCEROL ACYLTRANSFERASE 1; FATTY ACID BINDING PROTEIN; GELATINASE A; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; ACYLATION STIMULATING PROTEIN, HUMAN; CHEMOKINE RECEPTOR; GPR77 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOLYSIS; MALE; MICROARRAY ANALYSIS; MORBID OBESITY; NUCLEOTIDE SEQUENCE; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS TISSUE; TISSUE PRESERVATION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; METABOLISM; MIDDLE AGED; OBESITY; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADULT; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; OBESITY; OMENTUM; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; TRIGLYCERIDES;

EID: 77649280049     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-3     Document Type: Article

References (58)

1. The prevalence and etiology of nongenetic obesity and associated disorders. RN Redinger, South Med J 2008 101 395 399
2. Adipose tissue and the insulin resistance syndrome. KN Frayn, Proc Nutr Soc 2001 60 375 380
3. The epidemiology of obesity: the size of the problem. WP James, J Intern Med 2008 263 336 352
4. Overweight: fat distribution and health risks. Epidemiological observations. A review. JC Seidell JG Hautvast P Deurenberg, Infusionstherapie 1989 16 276 281
5. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. G Reaven, Diab Vasc Dis Res 2005 2 105 112
6. Obesity, insulin resistance, and cardiovascular disease. G Reaven F Abbasi T McLaughlin, Recent Prog Horm Res 2004 59 207 223
7. Are there persons who are obese, but metabolically healthy? EA Sims, Metabolism 2001 50 1499 1504
8. Metabolic and body composition factors in subgroups of obesity: what do we know? AD Karelis DH St Pierre F Conus R Rabasa-Lhoret ET Poehlman, J Clin Endocrinol Metab 2004 89 2569 2575
9. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? M Brochu A Tchernof IJ Dionne CK Sites GH Eltabbakh EA Sims ET Poehlman, J Clin Endocrinol Metab 2001 86 1020 1025
10. The relationship between insulin resistance and cardiovascular risk factors in overweight/obese non-diabetic Asian adults: the 1992 Singapore National Health Survey. SC Lim BY Tan SK Chew CE Tan, Int J Obes Relat Metab Disord 2002 26 1511 1516
11. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. MJ Shin YJ Hyun OY Kim JY Kim Y Jang JH Lee, Int J Obes (Lond) 2006 30 1529 1534
12. Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. R MacLaren W Cui S Simard K Cianflone, J Lipid Res 2008 49 308 323
13. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk. P Calabro ET Yeh, Curr Hypertens Rep 2008 10 32 38
14. The metabolic syndrome and cardiovascular disease. E Bonora, Ann Med 2006 38 64 80
15. Critical review of acylation-stimulating protein physiology in humans and rodents. K Cianflone Z Xia LY Chen, Biochim Biophys Acta 2003 1609 127 143
16. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. D Kalant SA Cain M Maslowska AD Sniderman K Cianflone PN Monk, J Biol Chem 2003 278 11123 11129
17. C5L2 is a functional receptor for acylation-stimulating protein. D Kalant R MacLaren W Cui R Samanta PN Monk SA Laporte K Cianflone, J Biol Chem 2005 280 23936 23944
18. Targeting the signaling pathway of acylation stimulating protein. M Maslowska H Legakis F Assadi K Cianflone, J Lipid Res 2006 47 643 652
19. Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. D Kalant S Phelis BA Fielding KN Frayn K Cianflone AD Sniderman, J Lipid Res 2000 41 1963 1968
20. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Saleh LK Summers K Cianflone BA Fielding AD Sniderman KN Frayn, J Lipid Res 1998 39 884 891
21. The acylation-stimulating protein pathway and regulation of postprandial metabolism. AD Sniderman K Cianflone L Summers B Fielding K Frayn, Proc Nutr Soc 1997 56 703 712
22. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. K Cianflone R Zakarian C Couillard B Delplanque JP Despres A Sniderman, J Lipid Res 2004 45 124 131
23. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. M Maslowska H Vu S Phelis AD Sniderman BM Rhode D Blank K Cianflone, Eur J Clin Invest 1999 29 679 686
24. Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. H Yu Y Yang M Zhang H Lu J Zhang H Wang K Cianflone, Nutr Metab (Lond) 2006 3 13
25. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Y Yang HL Lu J Zhang HY Yu HW Wang MX Zhang K Cianflone, Int J Obes (Lond) 2006 30 439 446
26. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. DR Cottam SG Mattar E Barinas-Mitchell G Eid L Kuller DE Kelley PR Schauer, Obes Surg 2004 14 589 600
27. The adipose tissue as a source of vasoactive factors. G Fruhbeck, Curr Med Chem Cardiovasc Hematol Agents 2004 2 197 208
28. [Clinical significance of the quantification of obesity. The Quetelet index and its use]. P Sucharda, Cas Lek Cesk 1989 128 1040 1043
29. Significance analysis of microarrays applied to the ionizing radiation response. VG Tusher R Tibshirani G Chu, Proc Natl Acad Sci USA 2001 98 5116 5121
30. Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. K Gorzelniak J Janke S Engeli AM Sharma, Horm Metab Res 2001 33 625 627
31. Purification and characterization of acylation stimulating protein. KM Cianflone AD Sniderman MJ Walsh HT Vu J Gagnon MA Rodriguez, J Biol Chem 1989 264 426 430
32. The adipsin-ASP pathway and regulation of adipocyte function. AD Sniderman K Cianflone, Ann Med 1994 26 388 393
33. Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. PW Peake S O'Grady BA Pussell JA Charlesworth, Eur J Clin Invest 1997 27 922 927
34. Structure-function relationships of complement receptor type 1. M Krych-Goldberg JP Atkinson, Immunol Rev 2001 180 112 122
35. Alternative pathway evaluation. PC Giclas, Curr Protoc Immunol 2001 Chapter 13 Unit
36. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. NP Gerard B Lu P Liu S Craig Y Fujiwara S Okinaga C Gerard, J Biol Chem 2005 280 39677 39680
37. The adipocyte fatty acid-binding protein locus: characterization and association with intramuscular fat content in pigs. F Gerbens A Jansen AJ van Erp F Harders TH Meuwissen G Rettenberger JH Veerkamp MF te Pas, Mamm Genome 1998 9 1022 1026
38. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. A Chmurzynska, J Appl Genet 2006 47 39 48
39. Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome. S Takahashi T Tanaka T Kodama J Sakai, Pharmacol Res 2006 53 501 507
40. Remodeling phenotype of human subcutaneous adipose tissue macrophages. V Bourlier A Zakaroff-Girard A Miranville S De Barros M Maumus C Sengenes J Galitzky M Lafontan F Karpe KN Frayn, et al. Circulation 2008 117 806 815
41. Adipocyte death, adipose tissue remodeling, and obesity complications. KJ Strissel Z Stancheva H Miyoshi JW Perfield J DeFuria Z Jick AS Greenberg MS Obin, Diabetes 2007 56 2910 2918
42. The multiple facets of the fat tissue. VZ Rocha P Libby, Thyroid 2008 18 175 183
43. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. K Cianflone DA Roncari M Maslowska A Baldo J Forden AD Sniderman, Biochemistry 1994 33 9489 9495
44. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. A Baldo AD Sniderman S St Luce RK Avramoglu M Maslowska B Hoang JC Monge A Bell S Mulay K Cianflone, J Clin Invest 1993 92 1543 1547
45. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. M Maslowska T Scantlebury R Germinario K Cianflone, J Lipid Res 1997 38 1 11
46. Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. T Scantlebury M Maslowska K Cianflone, J Biol Chem 1998 273 20903 20909
47. Regional specificity of ASP binding in human adipose tissue. J Saleh N Christou K Cianflone, Am J Physiol 1999 276 815 E821
48. Acylation-stimulating protein precursor proteins in adipose tissue in human obesity. Z Xia K Cianflone, Metabolism 2003 52 1360 1366
49. High expression of complement components in omental adipose tissue in obese men. BG Gabrielsson JM Johansson M Lonn M Jernas T Olbers M Peltonen I Larsson L Lonn L Sjostrom B Carlsson, et al. Obes Res 2003 11 699 708
50. C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients. K Ylitalo I Nuotio J Viikari J Auwerx H Vidal MR Taskinen, Metabolism 2002 51 664 670
51. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. HA Koistinen H Vidal SL Karonen E Dusserre P Vallier VA Koivisto P Ebeling, Arterioscler Thromb Vasc Biol 2001 21 1034 1039
52. Age-related differences in messenger ribonucleic acid expression of key proteins involved in adipose cell differentiation and metabolism. P Imbeault H Vidal A Tremblay N Vega A Nadeau JP Despres P Mauriege, J Clin Endocrinol Metab 2001 86 828 833
53. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. E Dusserre P Moulin H Vidal, Biochim Biophys Acta 2000 1500 88 96
54. Substrate cycling between triglyceride and fatty acid in human adipocytes. VA Hammond DG Johnston, Metabolism 1987 36 308 313
55. Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). G Medina-Gomez S Gray A Vidal-Puig, Public Health Nutr 2007 10 1132 1137
56. Inflammation is associated with a decrease of lipogenic factors in omental fat in women. O Poulain-Godefroy C Lecoeur F Pattou G Fruhbeck P Froguel, Am J Physiol Regul Integr Comp Physiol 2008 295 R1-7
57. Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. M Maslowska HW Wang K Cianflone, Vitam Horm 2005 70 309 332
58. Endophyte-Infected Tall Fescue Diet Alters Gene Expression in Heifer Luteal Tissue as Revealed by Interspecies Microarray Analysis. KL Jones SS Kins MJ Iqbal, Molecular Reproductive Developement 2004 67 154 161